2022 conference-abstract

EP08.02-139 A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs

Shan-Shan Lu, Yanrong Zhang, G. Zhang, Jiangli Zhou, S. Cang, Y. Cheng, Guojia Wu, Puyu Cao, Diandong Lv, Hongtao Jian, C. Chen, X. Jin, P. Tian, K. Wang, Guan-lu Jiang, G. Chen, Q. Chen, H. Zhao, Chaopu Ding, R. Guo, Guozhen Sun, B. Wang, Leyao Jiang, Zongmei Liu, Jiacheng Fang, Jiaxu Yang, W. Zhuang, Y. Liu, Jingliang Zhang, Y. Pan, J. Chen, Q. Yu, M. Zhao, J. Cui, D. Li, T. Yi, Zhaoxing Yu, Yunting Yang, Xuyang Zhi, Y. Huang, Rihan Wu, Laixiu Chen, A. Zang, L. Cao, Qianfan Li, Xuantao Li, Yinghui Song, D. Wang, Shuang Zhang

1Citations signalées — pas une note de qualité

61Institutions déclarées

1Pays d’affiliation déclarés

Résumé indisponible : les résultats de l’étude ne doivent pas être déduits depuis son seul titre.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref: EP08.02-139 A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
Date Crossref: 01/09/2022
Éditeur: Elsevier BV
Type: journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Shanghai Chest Hospital Zhejiang Cancer Hospital First Hospital of Shijiazhuang University of Chinese Academy of Sciences First Affiliated Hospital of Zhengzhou University First Affiliated Hospital Zhejiang University Henan Provincial People's Hospital Jilin Province Tumor Hospital Wuhan Union Hospital Union Hospital Central South University Third Xiangya Hospital Wenzhou Medical University Zhejiang Taizhou Hospital First Affiliated Hospital of Wenzhou Medical University Ningxia Medical University Ningxia Medical University General Hospital Sichuan University West China Hospital of Sichuan University Second Affiliated Hospital of Zhejiang University Dongguan People’s Hospital Harbin Medical University Third Affiliated Hospital of Harbin Medical University Fuzhou Pulmonary Hospital of Fujian Anhui Medical University Second Affiliated Hospital of Anhui Medical University Hebei Medical University Fourth Hospital of Hebei Medical University Nanjing Medical University First Affiliated Hospital of Anhui Medical University Huzhou Central Hospital Capital Medical University Beijing Chest Hospital Peking University Peking University Cancer Hospital Tangshan People's Hospital Fujian Provincial Cancer Hospital First Hospital of China Medical University China Medical University Air Force Medical University University of Science and Technology of China Anhui Provincial Hospital Tianjin Medical University General Hospital Guangxi Medical University Tumor Hospital of Guangxi Medical University Jilin University First Hospital of Jilin University First Affiliated Hospital of Bengbu Medical College Xiangyang Central Hospital Qingdao University Affiliated Hospital of Qingdao University Chifeng Municipal Hospital Xuan Wu Hospital of the Capital Medical University Kunming Medical University Chinese PLA General Hospital Affiliated Hospital of Hebei University Affiliated Hospital of Chengde Medical College Liaoning Cancer Hospital & Institute Jinling Institute of Technology Nanjing University Chongqing Cancer Hospital

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Lung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesGastric Cancer Management and Outcomes

Consulter la publication primaire DOI

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.